Drs. Hidehito Horinouchi and Stephen Liu will chair the session, which will explore multiple advances driving survival gains, including antibody-drug conjugates, bispecific T-cell engagers, and targeted therapies. Read more

Members are invited to join the meeting and learn about the new plan, which will guide the association for the next 5 years. Read more

In addition to thought-provoking keynotes from Her Royal Highness Princess Dina Mired and Dr. Gary Rodin, the official kickoff of #WCLC23 included a lively celebration of the meeting’s host city. Read more

Investigator Dr. Ying Cheng says study results support the use of immunochemotherapy plus anti-angiogenesis as a new treatment option in a difficult-to-treat patient population. Read more

Make time to visit the Exhibit Hall this evening to talk with poster presenters about their research. Read more

The symposium also marks a change in IASLC leadership as Dr. Heather Wakelee will deliver the final Presidential Address of her term. Read more

IASLC Staging and Prognostic Factors Committee Chair Dr. Hisao Asamura joins Drs. Valerie Rusch and Enrico Ruffini to review updates in lung cancer, mesothelioma, and thymic cancer. Read more

The IASLC Cancer Care Team award highlights the teamwork required to provide the best possible patient care. Read more

Since WCLC 2022, JTO, led by Dr. Alex A. Adjei, has continued to increase its impact factor, and JTO CRR has welcomed a new Editor-in-Chief, Dr. Emily Stone. Read more

In an exclusive interview, Princess Dina talks with ILCN about her passion for improving equitable access to cancer care, tobacco control, prevention, and more. Read more